597 related articles for article (PubMed ID: 10580423)
1. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
2. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced desensitization of insulinotropic actions of sulfonylureas.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Biochem Biophys Res Commun; 2000 Apr; 271(1):234-9. PubMed ID: 10777708
[TBL] [Abstract][Full Text] [Related]
4. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
Chan SL; Dunne MJ; Stillings MR; Morgan NG
Eur J Pharmacol; 1991 Oct; 204(1):41-8. PubMed ID: 1687123
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
Chan SL; Mourtada M; Morgan NG
Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
[TBL] [Abstract][Full Text] [Related]
6. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
Bleck C; Wienbergen A; Rustenbeck I
Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
[TBL] [Abstract][Full Text] [Related]
7. Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposure.
McClenaghan NH; Ball AJ; Flatt PR
Biochem Pharmacol; 2001 Mar; 61(5):527-36. PubMed ID: 11239495
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
9. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
Shepherd RM; Hashmi MN; Kane C; Squires PE; Dunne MJ
Br J Pharmacol; 1996 Nov; 119(5):911-6. PubMed ID: 8922740
[TBL] [Abstract][Full Text] [Related]
10. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
11. PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic beta-cells.
Koriyama N; Kakei M; Nakazaki M; Yaekura K; Ichinari K; Gong Q; Morimitsu S; Yada T; Tei C
Diabetes; 2000 Nov; 49(11):1830-9. PubMed ID: 11078449
[TBL] [Abstract][Full Text] [Related]
12. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.
Szollosi A; Nenquin M; Henquin JC
Br J Pharmacol; 2010 Feb; 159(3):669-77. PubMed ID: 20128805
[TBL] [Abstract][Full Text] [Related]
14. Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells.
Dunne MJ
Br J Pharmacol; 1990 Mar; 99(3):487-92. PubMed ID: 2158844
[TBL] [Abstract][Full Text] [Related]
15. Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells.
Rustenbeck I; Kowalewski R; Herrmann C; Dickel C; Ratzka P; Hasselblatt A
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():42-5. PubMed ID: 8839253
[TBL] [Abstract][Full Text] [Related]
16. RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin.
Bränström R; Höög A; Wahl MA; Berggren PO; Larsson O
FEBS Lett; 1997 Jul; 411(2-3):301-7. PubMed ID: 9271225
[TBL] [Abstract][Full Text] [Related]
17. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
Rustenbeck I; Dickel C; Grimmsmanns T
Biochem Pharmacol; 2001 Dec; 62(12):1695-703. PubMed ID: 11755123
[TBL] [Abstract][Full Text] [Related]
19. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets.
Straub SG; James RF; Dunne MJ; Sharp GW
Diabetes; 1998 May; 47(5):758-63. PubMed ID: 9588447
[TBL] [Abstract][Full Text] [Related]
20. Imidazolines and the pancreatic B-cell. Actions and binding sites.
Rustenbeck I; Köpp M; Ratzka P; Leupolt L; Hasselblatt A
Ann N Y Acad Sci; 1999 Jun; 881():229-40. PubMed ID: 10415921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
